Literature DB >> 24114720

Assessment for retreatment (ART) score for repeated transarterial chemoembolization in patients with hepatocellular carcinoma.

Masatoshi Kudo1, Tadaaki Arizumi, Kazuomi Ueshima.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24114720     DOI： 10.1002/hep.26760

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  14 in total

Review 1.  Recommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?

Authors:  Xavier Adhoute; Guillaume Penaranda; Paul Castellani; Herve Perrier; Marc Bourliere
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients.

Authors:  Antonio Facciorusso; Raffaele Licinio; Nicola Muscatiello; Alfredo Di Leo; Michele Barone
Journal:  World J Hepatol       Date:  2015-08-08

Review 3.  Patient Selection for Transarterial Chemoembolization in Hepatocellular Carcinoma: Importance of Benefit/Risk Assessment.

Authors:  Fabio Piscaglia; Sadahisa Ogasawara
Journal:  Liver Cancer       Date:  2018-01-12       Impact factor: 11.740

4.  Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: a multi-center comparative study.

Authors:  David J Pinato; Tadaaki Arizumi; Jeong Won Jang; Elias Allara; Puvan I Suppiah; Carlo Smirne; Paul Tait; Madhava Pai; Glenda Grossi; Young Woon Kim; Mario Pirisi; Masatoshi Kudo; Rohini Sharma
Journal:  Oncotarget       Date:  2016-07-12

5.  All-treatment array of hepatocellular carcinoma from initial diagnosis to death: observation of cumulative treatments.

Authors:  Hae Moon; Ji Eun Choi; In Joon Lee; Tae Hyun Kim; Seong Hoon Kim; Young Hwan Ko; Hyun Boem Kim; Byung-Ho Nam; Joong-Won Park
Journal:  J Cancer Res Clin Oncol       Date:  2017-07-25       Impact factor: 4.553

6.  Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma.

Authors:  David J Pinato; Madhava Pai; Isabella Reccia; Markand Patel; Alexandros Giakoustidis; Georgios Karamanakos; Azelea Rushd; Shiraz Jamshaid; Alberto Oldani; Glenda Grossi; Mario Pirisi; Paul Tait; Rohini Sharma
Journal:  BMC Cancer       Date:  2018-02-20       Impact factor: 4.430

7.  Tumor Marker-Based Definition of the Transarterial Chemoembolization-Refractoriness in Intermediate-Stage Hepatocellular Carcinoma: A Multi-Cohort Study.

Authors:  Jun Sik Yoon; Dong Hyun Sinn; Jeong-Hoon Lee; Hwi Young Kim; Cheol-Hyung Lee; Sun Woong Kim; Hyo Young Lee; Joon Yeul Nam; Young Chang; Yun Bin Lee; Eun Ju Cho; Su Jong Yu; Hyo-Cheol Kim; Jin Wook Chung; Yoon Jun Kim; Jung-Hwan Yoon
Journal:  Cancers (Basel)       Date:  2019-11-04       Impact factor: 6.639

Review 8.  How to define transarterial chemoembolization failure or refractoriness: a European perspective.

Authors:  Jean-Luc Raoul; Marine Gilabert; Gilles Piana
Journal:  Liver Cancer       Date:  2014-05       Impact factor: 11.740

Review 9.  Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy.

Authors:  Ji Hye Jang; Jin-Woo Lee; Ji Taek Hong; Young-Joo Jin
Journal:  J Hepatocell Carcinoma       Date:  2015-09-02

10.  The Effectiveness of ART Score in Selecting Patients for Transarterial Chemoembolization Retreatment: A Cohort Study in Taiwan.

Authors:  Chi-Lung Tseng; Wei-Jen Lai; Chun-Jui Huang; Yi-Hsiang Huang; Chien-Wei Su; I-Cheng Lee; Hsiou-Shan Tseng; Chung-Pin Li; Rheun-Chuan Lee; Han-Chieh Lin; Yee Chao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.